Literature DB >> 32443763

Increased Cell-Free DNA Plasma Concentration Following Liver Transplantation Is Linked to Portal Hepatitis and Inferior Survival.

Felix Krenzien1,2, Shadi Katou3, Alba Papa1,2, Bruno Sinn2,4, Christian Benzing1,2, Linda Feldbrügge1,2, Can Kamali1,2, Philipp Brunnbauer1,2, Katrin Splith1,2, Ralf Roland Lorenz1,2, Paul Ritschl1,2, Leke Wiering1,2, Robert Öllinger1,2, Wenzel Schöning1,2, Johann Pratschke1,2, Moritz Schmelzle1,2.   

Abstract

Donor organ quality is crucial for transplant survival and long-term survival of patients after liver transplantation. Besides bacterial and viral infections, endogenous damage-associated molecular patterns (DAMPs) can stimulate immune responses. Cell-free DNA (cfDNA) is one such DAMP that exhibits highly proinflammatory effects via DNA sensors. Herein, we measured cfDNA after liver transplantation and found elevated levels when organs from resuscitated donors were transplanted. High levels of cfDNA were associated with high C-reactive protein, leukocytosis as well as granulocytosis in the recipient. In addition to increased systemic immune responses, portal hepatitis was observed, which was associated with increased interface activity and a higher numbers of infiltrating neutrophils and eosinophils in the graft. In fact, the cfDNA was an independent significant factor in multivariate analysis and increased concentration of cfDNA was associated with inferior 1-year survival. Moreover, cfDNA levels were found to be decreased significantly during the postoperative course when patients underwent continuous veno-venous haemofiltration. In conclusion, patients receiving livers from resuscitated donors were characterised by high postoperative cfDNA levels. Those patients showed pronounced portal hepatitis and systemic inflammatory responses in the short term leading to a high mortality. Further studies are needed to evaluate the clinical relevance of cfDNA clearance by haemoadsorption and haemofiltration in vitro and in vivo.

Entities:  

Keywords:  C-reactive proteins; cell-free DNA; cfDNA; damage-associated molecular patterns; liver transplantation; portal hepatitis; sepsis; systemic immune response

Year:  2020        PMID: 32443763     DOI: 10.3390/jcm9051543

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

1.  Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers.

Authors:  Sohan Punia; Brian D Juran; Ahmad H Ali; Erik M Schlicht; Raymond M Moore; Zhifu Sun; Konstantinos N Lazaridis
Journal:  BMC Gastroenterol       Date:  2021-04-01       Impact factor: 3.067

Review 2.  Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

Authors:  Stéphanie Gonvers; Parissa Tabrizian; Emmanuel Melloul; Olivier Dormond; Myron Schwartz; Nicolas Demartines; Ismail Labgaa
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

Review 3.  Organ Restoration With Normothermic Machine Perfusion and Immune Reaction.

Authors:  Alessandro Parente; Daniel-Clement Osei-Bordom; Vincenzo Ronca; M Thamara P R Perera; Darius Mirza
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.